Biosafety in surgical pathology in the era of SARS-Cov2 pandemia. A statement of the Italian Society of Surgical Pathology and Cytology

Affiliations

• ¹ Unit of Surgical Pathology, S. Chiara Hospital, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
• ² Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Italy.
• ³ Unit of Surgical Pathology and Cytogenetics, Niguarda Cancer Center, Milano, Italy.
• ⁴ Department of Pathology, Azienda USL/IRCCS Reggio Emilia, Italy.
• ⁵ Unit of Surgical Pathology, Ospedale Fracastoro, San Bonifacio (VR), Italy.
• ⁶ Unit of Surgical Pathology, Ospedale di Lecco, Italy.
• ⁷ Department of Molecular and Translational Medicine, Pathology Unit, University of Brescia School of Medicine, Spedali Civili Brescia, Italy.
• ⁸ Division of Anatomic Pathology and Histology, Catholic University of Sacred Heart, Fondazione Policlinico Univeristario A. Gemelli, Rome, Italy.
• ⁹ Unit of Surgical Pathology, Ospedale di Macerata, Italy.
• ¹⁰ Department of Pathology, Cannizzaro Hospital, Catania, Italy.
• ¹¹ Pathology Unit, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo (FG), Italy.
• ¹² Unit of Protection and Prevention, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
• ¹³ Operative Unit of Pathology, Azienda USL della Romagna, St. Maria delle Croci Hospital, Ravenna, Italy.
• ¹⁴ Unit of Surgical Pathology, Ospedale S. Maurizio di Bolzano, Italy.
• ¹⁵ Department of Medical Sciences, University of Torino, Italy.
• ¹⁶ Candiolo Cancer Center, FPO-IRCCS, Candiolo (Torino), Italy.